rs1544514

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000719.7(CACNA1C):​c.522G>A​(p.Ala174Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.193 in 1,603,596 control chromosomes in the GnomAD database, including 31,499 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2420 hom., cov: 33)
Exomes 𝑓: 0.20 ( 29079 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0370

Publications

21 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 12-2449020-G-A is Benign according to our data. Variant chr12-2449020-G-A is described in ClinVar as Benign. ClinVar VariationId is 93412.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.037 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.522G>Ap.Ala174Ala
synonymous
Exon 4 of 47NP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.522G>Ap.Ala174Ala
synonymous
Exon 4 of 47NP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.522G>Ap.Ala174Ala
synonymous
Exon 4 of 50NP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.522G>Ap.Ala174Ala
synonymous
Exon 4 of 47ENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.522G>Ap.Ala174Ala
synonymous
Exon 4 of 47ENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.612G>Ap.Ala204Ala
synonymous
Exon 4 of 50ENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
AF:
0.169
AC:
25617
AN:
151994
Hom.:
2420
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0971
Gnomad AMI
AF:
0.315
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.291
Gnomad EAS
AF:
0.0615
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.167
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.176
AC:
42748
AN:
242448
AF XY:
0.179
show subpopulations
Gnomad AFR exome
AF:
0.0951
Gnomad AMR exome
AF:
0.159
Gnomad ASJ exome
AF:
0.290
Gnomad EAS exome
AF:
0.0644
Gnomad FIN exome
AF:
0.164
Gnomad NFE exome
AF:
0.209
Gnomad OTH exome
AF:
0.202
GnomAD4 exome
AF:
0.196
AC:
284454
AN:
1451484
Hom.:
29079
Cov.:
28
AF XY:
0.196
AC XY:
141705
AN XY:
722124
show subpopulations
African (AFR)
AF:
0.0942
AC:
3142
AN:
33354
American (AMR)
AF:
0.160
AC:
7070
AN:
44170
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
7398
AN:
25922
East Asian (EAS)
AF:
0.0719
AC:
2850
AN:
39644
South Asian (SAS)
AF:
0.150
AC:
12761
AN:
85270
European-Finnish (FIN)
AF:
0.166
AC:
8837
AN:
53226
Middle Eastern (MID)
AF:
0.216
AC:
1241
AN:
5746
European-Non Finnish (NFE)
AF:
0.208
AC:
229778
AN:
1104136
Other (OTH)
AF:
0.190
AC:
11377
AN:
60016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
9883
19766
29648
39531
49414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7842
15684
23526
31368
39210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25623
AN:
152112
Hom.:
2420
Cov.:
33
AF XY:
0.166
AC XY:
12325
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0970
AC:
4026
AN:
41486
American (AMR)
AF:
0.184
AC:
2817
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.291
AC:
1012
AN:
3472
East Asian (EAS)
AF:
0.0617
AC:
320
AN:
5190
South Asian (SAS)
AF:
0.147
AC:
707
AN:
4812
European-Finnish (FIN)
AF:
0.167
AC:
1766
AN:
10580
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14272
AN:
67980
Other (OTH)
AF:
0.168
AC:
355
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1105
2211
3316
4422
5527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.199
Hom.:
7881
Bravo
AF:
0.167
Asia WGS
AF:
0.0870
AC:
305
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
-
1
not provided (1)
-
-
1
Timothy syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
13
DANN
Benign
0.78
PhyloP100
0.037
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1544514; hg19: chr12-2558186; COSMIC: COSV59719439; API